📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
45 announcements match the current filters (relevance ≥ 5).
Indo Borax FY26 PAT Grows 18% to ₹50.27 Cr; Declares Massive ₹40 Total Dividend
Indo Borax reported a strong FY26 with revenue growing 22.9% YoY to ₹215.45 crore and PAT increasing to ₹50.27 crore. The company underwent a significant management shift with Zenrock Chemicals becoming the new promoter and a new leadership team taking charge. Shareholders were rewarded with a massive total dividend of ₹40 per share (4000%), including a ₹30 special dividend funded by the sale of non-core assets. Management has provided a positive outlook with a revenue target of ₹250+ crore for FY27.
Key Highlights
Q4 FY26 PAT surged 41.9% YoY to ₹14.53 crore with PAT margins improving by 250 bps to 21.5%.
Declared a total dividend of ₹40 per share for FY26, including a ₹30 special dividend from non-core asset sales.
Maintains a dominant 50% market share in the Indian Boric Acid market and operates with near-zero debt.
Revenue guidance for FY27 set at ₹250+ crore, driven by capacity debottlenecking and expansion in the DOT segment.
Successful transition to new promoter Zenrock Chemicals and a new leadership team led by CEO Suresh Kalra.
👀 What to Watch
Investors should take note of the significant value unlocking through the special dividend and the new management's aggressive growth targets. Monitor the upcoming CAPEX announcements and the company's ability to scale the high-margin DOT and IP-grade segments.
Indo Borax FY26 PAT Up 18% to ₹50.27 Cr; Announces ₹40 Total Dividend per Share
Indo Borax & Chemicals Limited reported a strong financial performance for FY26, with consolidated revenue growing 22.9% YoY to ₹215.45 Cr and PAT increasing 18.3% to ₹50.27 Cr. The company maintained a healthy EBITDA margin of 20.5% and remains a zero-debt entity with a dominant 50% market share in the domestic Boric Acid market. A major ownership transition was completed in January 2026, where institutional investors led by Zenrock Chemicals acquired a 50.80% controlling stake. To reward shareholders, the board announced a total dividend of ₹40 per share, including a ₹30 special dividend.
Key Highlights
Consolidated FY26 revenue increased 22.9% YoY to ₹215.45 Cr, while Q4FY26 revenue grew 25.7% YoY.
Full-year PAT rose 18.3% to ₹50.27 Cr, with Q4FY26 PAT showing a significant jump of 41.9% YoY to ₹14.53 Cr.
Announced a substantial dividend payout of ₹40 per share (₹10 final + ₹30 special) on a face value of ₹1.
Institutional investors acquired a 50.80% controlling stake in January 2026, signaling a strategic management transition.
Maintained zero-debt status and a strong market position with 20,000 MTPA Boric Acid capacity.
👀 What to Watch
The massive dividend payout and entry of institutional promoters are strong positive catalysts for the stock. Investors should monitor the new leadership's execution of expansion strategies and operational optimizations.
Indo Borax FY26 Revenue Rises 23% to ₹215.45 Cr; Earnings Call Set for June 2
Indo Borax & Chemicals Limited has announced its earnings call for June 2, 2026, following a strong financial performance in FY26. The company reported a 22.9% increase in consolidated operating revenue, reaching ₹215.45 crore compared to ₹175.26 crore in FY25. Consolidated Profit After Tax (PAT) also grew significantly to ₹50.27 crore from ₹42.51 crore in the previous year. The management team, including the MD and CFO, will discuss these results and future outlook during the scheduled call.
Key Highlights
Consolidated Operating Revenue grew 22.9% YoY to ₹215.45 crore in FY26.
Consolidated PAT increased by 18.2% YoY to ₹50.27 crore for the full year.
Earnings conference call scheduled for June 2, 2026, at 4:00 PM IST.
Company maintains a strong market position as a leading manufacturer of boron-based chemicals with 45+ years of expertise.
Management representation includes MD & CEO Suresh Katra and CFO Shashikant Bharuka.
👀 What to Watch
Investors should attend or review the earnings call transcripts to understand the drivers behind the 18% PAT growth and management's guidance on boron chemical demand. The stock remains a watch for those interested in niche chemical manufacturers with consistent profitability.
Indo Borax Declares ₹40 Total Dividend; FY26 Revenue Up 23% YoY to ₹215.45 Cr
Indo Borax & Chemicals Limited reported a strong financial performance for FY26, with revenue from operations growing 23% to ₹215.45 crore. The board recommended a massive total dividend of ₹40 per share, which includes a ₹10 final dividend and a ₹30 special dividend. Profit before tax increased to ₹65.81 crore, supported by an exceptional gain of ₹10.15 crore. Investors should note the ongoing NCLT proceedings regarding a ₹5.09 crore inter-corporate deposit which remains unprovided for.
Key Highlights
Total dividend of ₹40 per share (4000% of face value), including a ₹30 special dividend.
Annual Revenue from Operations increased 23% YoY to ₹215.45 crore from ₹175.26 crore.
Profit Before Tax (PBT) rose to ₹65.81 crore for FY26 compared to ₹57.83 crore in FY25.
Exceptional gain of ₹10.15 crore recorded during the financial year.
Company is pursuing recovery of a ₹5.09 crore inter-corporate deposit through NCLT; no interest is being recognized.
👀 What to Watch
The significant special dividend makes the stock highly attractive for income-seeking investors, while the underlying revenue growth shows business strength. Investors should maintain a watch on the NCLT outcome for the outstanding loan recovery.
Indo Borax FY26 Profit Rises to ₹65.8 Cr; Announces Total Dividend of ₹40 Per Share
Indo Borax & Chemicals reported a strong performance for FY26, with annual revenue from operations growing 23% to ₹215.45 crore. The company has rewarded shareholders with a massive total dividend of ₹40 per share, which includes a ₹10 final dividend and a ₹30 special dividend. Profit before tax increased to ₹65.81 crore from ₹57.83 crore in the previous fiscal year. Investors should note an emphasis of matter regarding a ₹5.09 crore inter-corporate deposit currently under NCLT proceedings for recovery.
Key Highlights
Revenue from operations grew 23% YoY to ₹215.45 crore in FY26 compared to ₹175.26 crore in FY25.
Total dividend of ₹40 per share declared (4000% of face value), including a ₹30 special dividend.
Profit before tax (PBT) rose to ₹65.81 crore in FY26 from ₹57.83 crore in FY25.
Exceptional items for the year contributed ₹10.15 crore to the bottom line.
Company is pursuing recovery of a ₹5.09 crore loan through NCLT, with no interest being recognized currently.
👀 What to Watch
The significant special dividend makes this a highly positive outcome for yield-seeking investors, though it is likely a one-time event. Long-term investors should monitor the company's ability to maintain revenue growth and the resolution of the NCLT recovery case.
Indo Borax Declares Massive ₹40 Total Dividend and Reports 23% Revenue Growth for FY26
Indo Borax & Chemicals has announced a substantial payout for FY26, consisting of a ₹10 final dividend and a ₹30 special dividend, totaling ₹40 per share on a face value of ₹1. The company's annual revenue grew by 23% YoY to ₹215.45 crore, while Profit Before Tax rose to ₹65.81 crore, bolstered by an exceptional gain of ₹10.15 crore. While operating margins saw some pressure, the total dividend payout of 4000% represents a significant return of capital to shareholders. Investors should note an ongoing NCLT matter regarding a ₹5.09 crore inter-corporate deposit.
Key Highlights
Declared a total dividend of ₹40 per share (₹10 final and ₹30 special) for FY 2025-26.
Annual Revenue from Operations increased to ₹215.45 crore in FY26 from ₹175.26 crore in FY25.
Profit Before Tax (PBT) reached ₹65.81 crore, including an exceptional gain of ₹10.15 crore.
Total income for the financial year grew 21% to ₹230.17 crore compared to the previous year.
Board approved the appointment of new Internal and Cost Auditors for the upcoming FY 2026-27.
👀 What to Watch
Investors should benefit from the high dividend yield; however, they should monitor if such high payouts are sustainable or driven by one-time exceptional gains. The stock is expected to react positively to the 4000% dividend announcement.
Indo Borax Announces Massive ₹40 Total Dividend and 23% Revenue Growth for FY26
Indo Borax & Chemicals has recommended a substantial total dividend of ₹40 per share for FY 2025-26, consisting of a ₹10 final dividend and a ₹30 special dividend. The company's annual revenue from operations grew 23% year-on-year to ₹215.45 crore, while Profit Before Tax rose to ₹65.81 crore from ₹57.83 crore. Despite the strong performance, the company highlighted a pending ₹5.09 crore recovery under NCLT proceedings. The board also approved the appointment of new internal and cost auditors for the upcoming financial year.
Key Highlights
Recommended a total dividend of ₹40 per share (₹10 Final + ₹30 Special) on a face value of ₹1
Annual Revenue from Operations increased 22.9% YoY to ₹215.45 crore in FY26
Profit Before Tax (PBT) for the full year rose to ₹65.81 crore compared to ₹57.83 crore in FY25
Q4FY26 Revenue stood at ₹63.01 crore, up from ₹50.12 crore in the same quarter last year
Company is pursuing a ₹5.09 crore claim as a financial creditor in NCLT for an outstanding inter-corporate deposit
👀 What to Watch
Investors should cheer the high dividend payout which signals strong cash reserves; the stock remains an attractive yield play. Monitor the NCLT proceedings regarding the ₹5.09 crore loan recovery for any potential write-backs or further provisions.
Indo Borax FY26 Revenue Up 23%, Announces Massive ₹40 Total Dividend Per Share
Indo Borax & Chemicals Limited reported a robust performance for the financial year ended March 31, 2026, with annual revenue from operations growing 22.9% to ₹215.45 crore. The company has announced a significant total dividend of ₹40 per share, comprising a ₹10 final dividend and a ₹30 special dividend, representing a 4000% payout on the ₹1 face value. While Profit Before Tax for the year rose to ₹65.81 crore, it was supported by an exceptional gain of ₹10.15 crore. Investors should remain aware of a ₹5.09 crore inter-corporate deposit currently stuck in NCLT proceedings with no interest being recognized.
Key Highlights
Annual Revenue from Operations increased by 22.9% YoY to ₹215.45 crore in FY26.
Recommended a total dividend of ₹40 per share (₹10 Final + ₹30 Special) for FY25-26.
Standalone Profit Before Tax for Q4 FY26 grew 38.6% YoY to ₹17.40 crore.
Full-year Profit Before Tax reached ₹65.81 crore, aided by an exceptional gain of ₹10.15 crore.
Outstanding Inter-corporate Deposit of ₹5.09 crore is under NCLT resolution with no interest provided for the year.
👀 What to Watch
The stock is likely to react positively to the massive dividend payout; however, investors should treat the ₹30 special dividend as a one-time event rather than recurring yield. Monitor the recovery status of the ₹5.09 crore loan currently in insolvency proceedings.
Indo Borax Shareholders Approve ESOP 2026 and Increased Investment Limits
Indo Borax & Chemicals Limited has successfully passed four key resolutions via postal ballot with overwhelming majority support. Shareholders approved the implementation of the 'ESOP 2026' plan and the grant of options exceeding 1% of issued capital to specific employees. Additionally, the company received approval to exceed statutory limits for investments, loans, and guarantees under Section 186 of the Companies Act, providing greater financial flexibility. A resolution for paying commissions to non-executive directors was also passed with nearly 100% support.
Key Highlights
Implementation of 'ESOP 2026' approved with 99.31% of votes in favor.
Shareholders authorized investments, loans, and guarantees exceeding Section 186 limits with 99.31% approval.
Approval granted for ESOP allocations exceeding 1% of issued capital to identified employees.
Total of 1.71 crore votes were polled, representing approximately 53.27% of the total shareholding.
Remuneration via commission for non-executive directors approved with a 99.99% majority.
👀 What to Watch
The approval of ESOPs and higher investment limits suggests a focus on talent retention and potential capital deployment for growth. Investors should monitor future disclosures to see how the expanded investment limits are utilized for strategic purposes.
Indo Borax Shareholders Approve Suresh Kalra as MD & CEO with 99.29% Votes
Indo Borax & Chemicals Limited has announced the results of its postal ballot, where shareholders approved eight key resolutions regarding board restructuring. Most significantly, Mr. Suresh Kalra was appointed as the Managing Director and CEO with 99.29% of the votes in favor. Mr. Harsh Malhotra was also appointed as an Executive Director with similar support. The board has been further strengthened by the appointment of three new Independent Directors, all receiving over 99.99% approval, indicating strong shareholder consensus for the new leadership.
Key Highlights
Appointment of Mr. Suresh Kalra as MD & CEO approved with 1,66,45,231 votes in favor (99.29%)
Mr. Harsh Malhotra appointed as Executive Director with 99.29% support from voting shareholders
Three Independent Directors and one Non-Executive Director appointed with near-unanimous 99.99% support
A total of 8 resolutions were passed via postal ballot conducted between March 17 and April 15, 2026
The leadership transition is backed by a significant majority of both promoter and public institutional shareholders
👀 What to Watch
The overwhelming support for the new MD and CEO suggests high investor confidence in the leadership transition. Shareholders should monitor the company's strategic direction and operational performance under the new management team.
Indo Borax to Implement ESOP 2026 Plan for Grant of 16.89 Lakh Equity Shares
Indo Borax & Chemicals Limited has issued a postal ballot notice to seek shareholder approval for the introduction of the 'ESOP 2026' scheme. The plan proposes to grant up to 16,88,950 stock options, which are convertible into an equal number of equity shares of Re. 1 face value each. The scheme is designed to attract and retain talent through equity-based incentives for eligible employees and directors. The remote e-voting period for shareholders is set from April 9, 2026, to May 8, 2026, with final results to be declared by May 12, 2026.
Key Highlights
Proposed issuance of up to 16,88,950 Employee Stock Options (ESOPs) under the 2026 Plan.
Each option is convertible into one equity share of face value Re. 1/- upon exercise.
The scheme will be implemented via a direct route involving fresh allotment of shares.
Remote e-voting period is scheduled from April 9, 2026, to May 8, 2026, with a cut-off date of April 3, 2026.
Promoters and Independent Directors are excluded from participating in the ESOP scheme.
👀 What to Watch
Investors should note the potential minor equity dilution and monitor the final approval of the resolution. This is generally a positive move for long-term management stability and employee alignment.
Indo Borax Appoints Suresh Kalra as MD & CEO with ₹7 Crore Annual Pay Package
Indo Borax & Chemicals is seeking shareholder approval via postal ballot for the appointment of Mr. Suresh Kalra as Managing Director and CEO for a five-year term effective January 23, 2026. The proposed compensation package is substantial, featuring a fixed salary of ₹3.50 crore and a performance-linked bonus of up to ₹3.50 crore tied to EBITDA targets. Furthermore, the appointee is eligible for ESOPs representing up to 5% of the company's fully diluted capital base. Shareholders can cast their votes electronically between March 17 and April 15, 2026.
Key Highlights
Appointment of Suresh Kalra as MD & CEO for a 5-year tenure starting January 23, 2026
Fixed annual salary set at ₹3.50 crore with performance-based annual increments
Performance bonus of up to ₹3.50 crore linked to achieving specific EBITDA targets
Eligibility for equity-linked incentives (ESOPs) up to 5% of the fully diluted capital base
Remote e-voting period scheduled from March 17, 2026, to April 15, 2026
👀 What to Watch
Investors should support the leadership transition but monitor the 5% potential equity dilution from ESOPs and track if the high compensation leads to improved EBITDA performance.
Indo Borax Appoints Shashikant Bharuka as CFO Effective March 6, 2026
Indo Borax & Chemicals Limited has appointed Mr. Shashikant Bharuka as its new Chief Financial Officer, effective March 6, 2026. Mr. Bharuka is a seasoned professional with over 24 years of post-qualification experience as a CA and CS. He has previously held significant financial roles at major listed pharmaceutical companies including Lupin, Unichem Laboratories, and Ajanta Pharma. This appointment is expected to strengthen the company's financial governance and reporting frameworks.
Key Highlights
Mr. Shashikant Bharuka appointed as CFO and Key Managerial Personnel effective March 6, 2026
Brings over 24 years of experience in finance, accounts, and tax compliance from public listed companies
Previously served 9 years at Unichem Laboratories managing audits and consolidation of foreign subsidiaries
Professional background includes roles at Lupin Limited, Ajanta Pharma, and IPCA Laboratories
The Board approved the appointment following recommendations from the Audit and Nomination committees
👀 What to Watch
Investors should view this as a positive step towards professionalizing management with an experienced industry veteran. Monitor the company's financial reporting and capital allocation strategies following his transition into the role.
Indo Borax Appoints Mr. Shashikant Bharuka as CFO Effective March 06, 2026
Indo Borax & Chemicals Limited has appointed Mr. Shashikant Bharuka as the Chief Financial Officer (CFO) and Key Managerial Personnel, effective March 06, 2026. Mr. Bharuka is a highly experienced professional with over 24 years of experience in finance and accounts, having worked with major listed firms like Lupin, Unichem Laboratories, and Ajanta Pharma. The Board also approved a draft Postal Ballot Notice for seeking shareholder approval on unspecified resolutions. This leadership addition is expected to strengthen the company's financial reporting and compliance oversight.
Key Highlights
Mr. Shashikant Bharuka appointed as CFO and Key Managerial Personnel effective March 06, 2026
Appointee is a qualified CA and CS with over 24 years of post-qualification experience in finance
Previous experience includes a 9-year tenure at Unichem Laboratories and senior roles at Lupin Limited
The Board approved a draft Postal Ballot Notice for upcoming shareholder resolutions
Appointment was based on recommendations from the Audit and Nomination & Remuneration Committees
👀 What to Watch
Investors should view the hiring of an experienced professional from larger pharmaceutical firms as a positive step for corporate governance. Monitor the upcoming Postal Ballot for details on other proposed resolutions.
Indo Borax Promoters to Complete 50.80% Stake Sale on Jan 23, 2026
Indo Borax & Chemicals has announced that its promoter group will complete the sale of a 50.80% stake in the company on January 23, 2026. The transaction involves the transfer of 1,63,00,230 equity shares to a consortium including Zenrock Chemicals Private Limited and India Special Assets Fund III. Upon completion, the existing promoters will cease to be in control and will be de-classified from the promoter group. This significant change in ownership marks a major transition for the company's management and strategic oversight.
Key Highlights
Transfer of 1,63,00,230 equity shares representing 50.80% of total paid-up capital
Transaction completion date finalized as January 23, 2026, via a new SPA Letter Agreement
Purchasers include Zenrock Chemicals and multiple India Special Assets/Situation Funds
Current promoters to be de-classified and will lose control of the company post-transfer
The company itself is not a party to the SPA Letter Agreement but is facilitating the disclosure
👀 What to Watch
Investors should closely monitor the incoming management's strategic plans and any potential open offer implications. The shift from a family-led promoter group to institutional and private equity ownership could lead to significant changes in operational focus.
Zenrock Chemicals Acquires 50.80% Stake in Indo Borax; Becomes New Promoter
Zenrock Chemicals Private Limited, along with India Special Assets Fund III and other purchasers, has completed the acquisition of 1,63,00,230 equity shares of Indo Borax & Chemicals Limited, representing a 50.80% stake. Following this transfer on January 23, 2026, the Acquirer has taken control of the company and is now classified as the new promoter. The erstwhile promoters, including Mr. Sajal Sushilkumar Jain and others, have exited their holdings and have been de-classified from the promoter group. An open offer for an additional 26.00% stake (83,43,400 shares) is also being undertaken for public shareholders.
Key Highlights
Acquisition of 1,63,00,230 equity shares representing 50.80% of the total paid-up equity capital.
Zenrock Chemicals and associated funds have officially become the new promoters of the company.
The transaction was completed on January 23, 2026, following a Share Purchase Agreement dated December 15, 2025.
An Open Offer is being conducted to acquire up to 83,43,400 additional shares (26.00% stake) from public shareholders.
The former promoter group has been entirely de-classified as they no longer hold shares or exercise control.
👀 What to Watch
Investors should closely monitor the Open Offer price and the strategic roadmap provided by the new management, Zenrock Chemicals. A change in control by institutional funds often leads to professionalization and potential re-rating of the company.
Indo Borax Promoters to Transfer 50.80% Stake; Completion Set for Jan 23, 2026
Indo Borax & Chemicals has announced the finalization of a major Share Purchase Agreement (SPA) involving the transfer of 1,63,00,230 equity shares. This transaction represents 50.80% of the company's total paid-up equity capital, moving from the existing promoter group to a consortium including Zenrock Chemicals and India Special Assets Fund III. Upon completion on January 23, 2026, the current sellers will cease to be in control and will be de-classified as promoters. This marks a significant shift in the company's ownership and potential management direction.
Key Highlights
Transfer of 1,63,00,230 equity shares representing 50.80% of total paid-up capital
Transaction completion date finalized as January 23, 2026
Purchasers include Zenrock Chemicals Private Limited and India Special Assets Fund III
Existing promoters to be de-classified and will cease to have control of the company
The company itself is not a party to the SPA Letter Agreement but is the subject of the transfer
👀 What to Watch
Investors should closely monitor the transition of power and any subsequent changes in business strategy or management by the new majority owners. The stock may see significant volatility as the market assesses the capabilities of the incoming controlling entities.
Indo Borax Promoters to Complete 50.80% Stake Sale on January 23, 2026
Indo Borax & Chemicals has announced that the completion date for a major Share Purchase Agreement (SPA) is set for January 23, 2026. The transaction involves the transfer of 1,63,00,230 equity shares, which represents 50.80% of the company's total paid-up equity capital. The current promoter group, including Mr. Sajal Sushilkumar Jain and others, will sell their stake to a group of purchasers including Zenrock Chemicals and India Special Assets Fund III. Following this completion, the existing sellers will cease to be in control and will be de-classified from the promoter group.
Key Highlights
Transfer of 1,63,00,230 equity shares representing 50.80% of total paid-up capital
Transaction completion date confirmed as January 23, 2026, via a letter agreement
Purchasers include Zenrock Chemicals Private Limited and India Special Assets Fund III
Current promoters will lose control and be de-classified under SEBI Regulation 31A(10)
The company itself is not a party to the SPA Letter Agreement but is the subject of the transfer
👀 What to Watch
Investors should closely monitor the transition of management and any strategic shifts introduced by the new majority shareholders. A change in control of over 50% is a critical event that may lead to significant changes in the company's operational direction.
Indo Borax Q3 FY26 Net Profit Rises 2.2% YoY to ₹9.27 Cr; Revenue Up 9.3%
Indo Borax & Chemicals reported a steady year-on-year performance for Q3 FY26, with consolidated revenue growing 9.3% to ₹41.02 crore. Consolidated net profit saw a marginal increase of 2.2% YoY, reaching ₹9.27 crore. The company experienced a significant sequential (QoQ) decline in performance because its Pithampur plant was shut down for 40 days (Oct 14 to Nov 22, 2025) for planned maintenance. Additionally, the company recognized a one-time benefit of ₹27.97 lakhs due to adjustments related to the New Labour Codes.
Key Highlights
Consolidated Revenue from Operations increased 9.3% YoY to ₹41.02 crore from ₹37.51 crore.
Consolidated Net Profit grew 2.2% YoY to ₹9.27 crore, while EPS stood at ₹2.89.
Pithampur plant shutdown for 40 days for boiler maintenance led to a ~29% QoQ revenue decline.
Nine-month consolidated net profit reached ₹35.74 crore, up from ₹32.26 crore in the previous year.
One-time decrease in employee benefit provision of ₹27.97 lakhs recognized due to New Labour Codes.
👀 What to Watch
The sharp sequential decline is attributable to a one-off plant maintenance shutdown rather than a loss of demand. Investors should monitor Q4 results to ensure production levels and margins return to normal operating capacity.
Zenrock Chemicals and Edelweiss Funds Launch Open Offer for 26% of Indo Borax at ₹256.30/Share
Zenrock Chemicals Private Limited, along with Edelweiss-backed funds, has issued a Draft Letter of Offer (DLOF) to acquire a 26% stake in Indo Borax & Chemicals Limited. The open offer is priced at ₹256.30 per share, targeting the acquisition of up to 83,43,400 equity shares. This mandatory offer follows the initial announcement in mid-December 2025 and is triggered by substantial acquisition regulations. The tendering period for public shareholders is tentatively scheduled to open on February 6, 2026.
Key Highlights
Open offer price fixed at ₹256.30 per equity share of face value ₹1 each
Acquisition target of 83,43,400 shares representing 26% of the company's voting share capital
Acquirers include Zenrock Chemicals and three Edelweiss-managed Alternative Investment Funds (PACs)
The total offer is payable in cash and is not subject to any minimum level of acceptance
Tentative schedule sets the offer opening date for February 6, 2026, and closing on February 19, 2026
👀 What to Watch
Investors should compare the offer price of ₹256.30 against the current market price to evaluate the premium or discount. It is advisable to wait for the recommendation of the Committee of Independent Directors, due by February 4, 2026, before deciding to tender shares.
